MHRA Drug Safety Update: October 2021

  • Home
  • News
  • MHRA Drug Safety Update: October 2021
Islington
Add to CPD

The October 2021 MHRA Drug Safety Update is available, including items on:

  • Tofacitinib (Xeljanzâ–Ľ): new measures to minimise risk of major adverse cardiovascular events and malignancies 
  • Chloral hydrate, cloral betaine (Welldorm): restriction of paediatric indication
  • MedSafetyWeek November 2021: support the safety of vaccines 
  • COVID-19 vaccines: updates for October 2021 
  • Letters and medicine recalls sent to healthcare professionals in September 2021

MHRA Drug Safety Update v15 issue 3 (October 2021)

w: https://assets.publishing.service.gov.uk
Expiry date: Dec 7th, 2021